Payment overview · 2025
General Payments
$116.01
2 reported records · 1 companies
Healthcare provider profile · identity verified
Ashwin Kumar, M.D.
Allopathic & Osteopathic Physicians|Family Medicine|Adult Medicine · AURORA, IL · NPI 1457517005
Verified facts
What the public records show
CMS Open Payments records show Ashwin Kumar, M.D. received $116.01 in general payments during 2025 across 2 reported records.
Medtronic, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$116.01 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $116.01 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SYMPLICITY G3 Normalized: symplicity g3 |
Device | Medtronic, Inc. | $88.21 | 1 | 2025 |
Source payment records
|
|||||
| ONYX FRONTIER Normalized: onyx frontier |
Device | Medtronic, Inc. | $27.80 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 542 | 152 |
| Atorvastatin Calcium | Atorvastatin Calcium | 521 | 156 |
| Lisinopril | Lisinopril | 436 | 127 |
| Levothyroxine Sodium | Levothyroxine Sodium | 358 | 97 |
| Metformin Hcl | Metformin Hcl | 347 | 88 |
| Metoprolol Succinate | Metoprolol Succinate | 307 | 86 |
| Omeprazole | Omeprazole | 302 | 95 |
| Losartan Potassium | Losartan Potassium | 289 | 86 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 282 | 38 |
| Pantoprazole Sodium | Pantoprazole Sodium | 270 | 76 |
| Simvastatin | Simvastatin | 252 | 62 |
| Hydrochlorothiazide | Hydrochlorothiazide | 204 | 57 |
| Alprazolam | Alprazolam | 192 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 192 | 59 |
| Gabapentin | Gabapentin | 135 | 36 |
| Alendronate Sodium | Alendronate Sodium | 125 | 37 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 116 | 42 |
| Glipizide Er | Glipizide | 109 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 106 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 100 | 37 |
| Allopurinol | Allopurinol | 98 | 28 |
| Furosemide | Furosemide | 96 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 91 | 20 |
| Metoprolol Tartrate | Metoprolol Tartrate | 88 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 87 | 36 |
| Trazodone Hcl | Trazodone Hcl | 82 | 26 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 78 | 13 |
| Atenolol | Atenolol | 75 | 22 |
| Tramadol Hcl | Tramadol Hcl | 70 | 16 |
| Glipizide | Glipizide | 68 | 19 |
| Metformin Hcl Er | Metformin Hcl | 66 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 62 | 20 |
| Lovastatin | Lovastatin | 62 | 18 |
| Carvedilol | Carvedilol | 61 | 14 |
| Donepezil Hcl | Donepezil Hcl | 57 | suppressed |
| Potassium Chloride | Potassium Chloride | 55 | 17 |
| Doxazosin Mesylate | Doxazosin Mesylate | 54 | 15 |
| Finasteride | Finasteride | 53 | 20 |
| Sertraline Hcl | Sertraline Hcl | 51 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 49 | 15 |
| Glimepiride | Glimepiride | 48 | 11 |
| Xarelto | Rivaroxaban | 48 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 45 | 13 |
| Ozempic | Semaglutide | 40 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 39 | 14 |
| Clonazepam | Clonazepam | 38 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | 11 |
| Ezetimibe | Ezetimibe | 38 | 11 |
| Enalapril Maleate | Enalapril Maleate | 37 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 34 | suppressed |
| Januvia | Sitagliptin Phosphate | 30 | suppressed |
| Diazepam | Diazepam | 29 | suppressed |
| Famotidine | Famotidine | 28 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 28 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 27 | suppressed |
| Temazepam | Temazepam | 27 | suppressed |
| Lorazepam | Lorazepam | 26 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 26 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Prednisone | Prednisone | 24 | 21 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 23 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 22 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 21 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 21 | suppressed |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Synthroid | Levothyroxine Sodium | 20 | suppressed |
| Eliquis | Apixaban | 19 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Baclofen | Baclofen | 18 | suppressed |
| Jardiance | Empagliflozin | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | suppressed |
| Meloxicam | Meloxicam | 16 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 16 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $116.01 · 2 records | Medtronic, Inc. | ONYX FRONTIER, SYMPLICITY G3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error